Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
10:27:08 EDT Sun 28 Apr 2024
Enter Symbol
or Name
USA
CA



Q:CMRX - CHIMERIX INC - http://www.chimerix.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CMRX - Q0.90.892·0.98640.10.8999+0.00891.0228.21715250.9091  0.9091  0.88151.57  0.8818:07:14Apr 2415 min RT 2¢

Recent Trades - Last 10 of 525
Time ETExPriceChangeVolume
18:07:14Q0.90490.013960
17:33:27Q0.8920.00150
17:33:27Q0.8950.004150
17:33:27Q0.8950.004150
17:33:27Q0.8920.001700
17:31:50Q0.9050.0143
17:21:42Q0.8990.0081,000
16:05:16Q0.89210.00111
16:01:31Q0.9050.0141
16:00:02Q0.89990.008943

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-24 07:00U:CMRXNews ReleaseChimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024
2024-04-16 16:05U:CMRXNews ReleaseChimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-03-21 07:00U:CMRXNews ReleaseChimerix Appoints Marc D. Kozin to Board of Directors
2024-02-29 07:00U:CMRXNews ReleaseChimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update
2024-02-27 07:00U:CMRXNews ReleaseChimerix to Present at TD Cowen 44th Annual Health Care Conference
2024-02-22 07:00U:CMRXNews ReleaseChimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024
2023-12-29 07:00U:CMRXNews ReleaseChimerix Appoints Lisa Decker to Board of Directors
2023-12-04 07:00U:CMRXNews ReleaseChimerix Promotes Michelle LaSpaluto to Chief Financial Officer
2023-11-24 07:00U:CMRXNews ReleaseChimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2023-11-16 07:00U:CMRXNews ReleaseChimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer
2023-11-02 07:00U:CMRXNews ReleaseChimerix Reports Third Quarter 2023 Financial Results and Provides Operational Update
2023-10-26 07:00U:CMRXNews ReleaseChimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023
2023-09-05 07:00U:CMRXNews ReleaseChimerix to Participate in Upcoming Investor Conferences
2023-08-16 10:05U:CMRXNews ReleaseChimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC201 Treatment of H3 K27M-Mutant Diffuse Midline Gliomas Published in "Cancer Discovery"
2023-08-03 07:00U:CMRXNews ReleaseChimerix Reports Second Quarter 2023 Financial Results and Provides Operational Update
2023-07-27 07:00U:CMRXNews ReleaseChimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023
2023-06-27 16:05U:CMRXNews ReleaseChimerix Announces Promotion of Michael T. Andriole to President and Chief Executive Officer
2023-05-31 16:01U:CMRXNews ReleaseChimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference
2023-05-25 07:00U:CMRXNews ReleaseChimerix to Participate in Cancer Moonshot Brain Cancers Forum on Glioblastoma (GBM) and Diffuse Intrinsic Pontine Glioma (DIPG) at White House
2023-05-04 07:00U:CMRXNews ReleaseChimerix Reports First Quarter 2023 Financial Results and Provides Operational Update